End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
11.79
CNY
|
-1.59%
|
|
-0.51%
|
-13.44%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
15,169
|
29,353
|
53,350
|
41,204
|
30,154
|
25,855
|
-
|
-
|
Enterprise Value (EV)
1 |
19,225
|
31,862
|
55,387
|
46,471
|
43,132
|
32,417
|
32,808
|
29,459
|
P/E ratio
|
56.3
x
|
186
x
|
16.1
x
|
14.8
x
|
38.9
x
|
24.8
x
|
11.1
x
|
13.3
x
|
Yield
|
0.89%
|
0.5%
|
1.01%
|
1.65%
|
1.47%
|
0.72%
|
1.99%
|
1.71%
|
Capitalization / Revenue
|
1.75
x
|
3.57
x
|
2.58
x
|
1.9
x
|
1.58
x
|
1.17
x
|
0.9
x
|
0.95
x
|
EV / Revenue
|
2.21
x
|
3.88
x
|
2.68
x
|
2.14
x
|
2.26
x
|
1.47
x
|
1.14
x
|
1.08
x
|
EV / EBITDA
|
22.9
x
|
36.1
x
|
9.7
x
|
10.3
x
|
20.3
x
|
7.02
x
|
5.95
x
|
5.91
x
|
EV / FCF
|
-19.1
x
|
-114
x
|
-32.4
x
|
-12.4
x
|
-7.05
x
|
44.8
x
|
55.3
x
|
21.5
x
|
FCF Yield
|
-5.23%
|
-0.88%
|
-3.08%
|
-8.05%
|
-14.2%
|
2.23%
|
1.81%
|
4.65%
|
Price to Book
|
1.28
x
|
2.37
x
|
3.71
x
|
1.79
x
|
1.36
x
|
1.13
x
|
0.95
x
|
0.97
x
|
Nbr of stocks (in thousands)
|
1,628,009
|
1,628,009
|
1,628,009
|
2,263,973
|
2,213,952
|
2,192,927
|
-
|
-
|
Reference price
2 |
9.317
|
18.03
|
32.77
|
18.20
|
13.62
|
11.79
|
11.79
|
11.79
|
Announcement Date
|
4/26/20
|
4/2/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
8,680
|
8,216
|
20,699
|
21,702
|
19,070
|
22,034
|
28,870
|
27,322
|
EBITDA
1 |
839.9
|
883.4
|
5,712
|
4,523
|
2,125
|
4,619
|
5,515
|
4,982
|
EBIT
|
372.6
|
308.8
|
4,699
|
3,397
|
1,041
|
-
|
3,939
|
2,678
|
Operating Margin
|
4.29%
|
3.76%
|
22.7%
|
15.65%
|
5.46%
|
-
|
13.64%
|
9.8%
|
Earnings before Tax (EBT)
1 |
353.2
|
262.9
|
4,674
|
3,395
|
988.5
|
1,154
|
2,959
|
2,310
|
Net income
1 |
269.8
|
138
|
3,340
|
2,691
|
765.3
|
1,068
|
2,392
|
2,010
|
Net margin
|
3.11%
|
1.68%
|
16.13%
|
12.4%
|
4.01%
|
4.85%
|
8.28%
|
7.36%
|
EPS
2 |
0.1655
|
0.0970
|
2.040
|
1.230
|
0.3500
|
0.4756
|
1.059
|
0.8892
|
Free Cash Flow
1 |
-1,005
|
-280.5
|
-1,708
|
-3,739
|
-6,118
|
724
|
593
|
1,369
|
FCF margin
|
-11.58%
|
-3.41%
|
-8.25%
|
-17.23%
|
-32.08%
|
3.29%
|
2.05%
|
5.01%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
15.68%
|
10.75%
|
27.47%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
67.76%
|
24.79%
|
68.1%
|
Dividend per Share
2 |
0.0828
|
0.0900
|
0.3300
|
0.3000
|
0.2000
|
0.0851
|
0.2345
|
0.2012
|
Announcement Date
|
4/26/20
|
4/2/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
4,056
|
2,509
|
2,038
|
5,266
|
12,978
|
6,563
|
6,954
|
3,604
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.829
x
|
2.84
x
|
0.3568
x
|
1.164
x
|
6.108
x
|
1.421
x
|
1.261
x
|
0.7234
x
|
Free Cash Flow
1 |
-1,005
|
-281
|
-1,708
|
-3,739
|
-6,118
|
724
|
593
|
1,369
|
ROE (net income / shareholders' equity)
|
2.4%
|
1.21%
|
23.8%
|
12.9%
|
3.35%
|
4.59%
|
9.16%
|
7.56%
|
ROA (Net income/ Total Assets)
|
1.11%
|
0.56%
|
10.3%
|
6.32%
|
-
|
2.23%
|
5.21%
|
4.18%
|
Assets
1 |
24,242
|
24,776
|
32,415
|
42,607
|
-
|
47,911
|
45,927
|
48,044
|
Book Value Per Share
2 |
7.260
|
7.620
|
8.830
|
10.20
|
10.00
|
10.40
|
12.50
|
12.20
|
Cash Flow per Share
2 |
0.5400
|
0.2000
|
-0.1700
|
0.2200
|
-0.0900
|
1.500
|
2.370
|
1.890
|
Capex
1 |
1,891
|
610
|
1,343
|
4,245
|
5,920
|
3,032
|
2,743
|
2,583
|
Capex / Sales
|
21.79%
|
7.42%
|
6.49%
|
19.56%
|
31.04%
|
13.76%
|
9.5%
|
9.45%
|
Announcement Date
|
4/26/20
|
4/2/21
|
4/19/22
|
4/19/23
|
4/25/24
|
-
|
-
|
-
|
Last Close Price
11.79
CNY Average target price
13.83
CNY Spread / Average Target +17.27% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.44% | 3.58B | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|